BiomX Inc. is a clinical-stage company developing phage-based therapies to target and kill specific harmful bacteria associated with chronic diseases. Its lead programs include BX011 (fixed phage cocktail for diabetic foot infections) and BX211 (personalized phage therapy for diabetic foot osteomyelitis), both targeting Staphylococcus aureus. The company discontinued BX004 (cystic fibrosis) and BX005 (atopic dermatitis) programs. In December 2025, its Israeli subsidiary commenced insolvency proceedings, and the company is pursuing strategic alternatives.
expected 2026-12-01
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-19 | 2025-12-31 | 0001213900-26-018231 | EDGAR | 81K words |
| 2025-03-25 | 2024-12-31 | 0001013762-25-002283 | EDGAR | 105K words |
| 2024-04-04 | 2023-12-31 | 0001213900-24-030053 | EDGAR | 97K words |
| 2023-03-29 | 2022-12-31 | 0001213900-23-024122 | EDGAR | — |
| 2022-03-30 | 2021-12-31 | 0001213900-22-016136 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001213900-21-019233 | EDGAR | — |
| 2020-03-26 | 2019-12-31 | 0001213900-20-007405 | EDGAR | — |
| 2019-08-21 | 2019-06-30 | 0001213900-19-016461 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-19 | 2026-06-30 | 0001213900-26-091780 | EDGAR | 31K words |
| 2025-11-12 | 2025-09-30 | 0001213900-25-109186 | EDGAR | 25K words |
| 2025-08-13 | 2025-06-30 | 0001213900-25-075328 | EDGAR | 23K words |
| 2025-05-15 | 2025-03-31 | 0001213900-25-044157 | EDGAR | 21K words |
| 2024-11-14 | 2024-09-30 | 0001213900-24-098523 | EDGAR | 27K words |
| 2024-08-14 | 2024-06-30 | 0001213900-24-068981 | EDGAR | 25K words |
| 2024-05-20 | 2024-03-31 | 0001213900-24-045273 | EDGAR | 21K words |
| 2023-11-14 | 2023-09-30 | 0001213900-23-086662 | EDGAR | 19K words |
| 2023-08-09 | 2023-06-30 | 0001213900-23-064926 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001213900-23-039734 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001213900-22-070435 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001213900-22-046257 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-25 | 0001213900-26-103251 | EDGAR | 2K words |
| 2026-09-22 | 0001213900-26-102245 | EDGAR | 4K words |
| 2026-09-15 | 0001213900-26-100156 | EDGAR | 3K words |
| 2026-09-09 | 0001213900-26-098212 | EDGAR | 1K words |
| 2026-09-01 | 0001213900-26-096273 | EDGAR | 1K words |
| 2026-08-28 | 0001213900-26-095146 | EDGAR | 1K words |
| 2026-08-25 | 0001213900-26-093565 | EDGAR | 1K words |
| 2026-08-11 | 0001213900-26-087839 | EDGAR | 4K words |
| 2026-07-28 | 0001213900-26-082025 | EDGAR | 1K words |
| 2026-04-01 | 0001213900-26-038095 | EDGAR | 10K words |
183 total filings indexed. 153 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001739174 |
| Ticker | PHGE |
| Exchange | NYSE |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.biomx.com |
| Listed | 2019-03-13 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/PHGE (~200 tokens, structured JSON with cryptographic provenance)